ProfileGDS4718 / 235060_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 81% 62% 57% 68% 78% 63% 70% 61% 77% 76% 62% 76% 67% 73% 58% 73% 68% 76% 65% 77% 68% 64% 71% 72% 74% 66% 83% 69% 78% 64% 63% 70% 72% 74% 79% 79% 59% 72% 61% 53% 68% 82% 70% 64% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.0300581
GSM549102patient 115, normal, homogenized [OPG study]6.2956662
GSM549104patient 119, normal, homogenized [OPG study]5.9606457
GSM549108patient 138, normal, homogenized [OPG study]6.6500568
GSM549119patient 077, normal, homogenized [OPG study]7.5482878
GSM549133patient 032, cancer, homogenized [OPG study]6.3574563
GSM549139patient 042, cancer, homogenized [OPG study]6.851170
GSM549099patient 107, normal, homogenized [OPG study]6.2023361
GSM549109patient 139, normal, homogenized [OPG study]7.4367977
GSM549110patient 046, normal, homogenized [OPG study]7.4186576
GSM549114patient 063, normal, homogenized [OPG study]6.2364662
GSM549122patient 082, normal, homogenized [OPG study]7.40176
GSM549134patient 033, cancer, homogenized [OPG study]6.6217167
GSM549136patient 036, cancer, homogenized [OPG study]7.2071873
GSM549140patient 044, cancer, homogenized [OPG study]5.9701658
GSM549111patient 047, normal, homogenized [OPG study]7.1579373
GSM549113patient 057, normal, homogenized [OPG study]6.758868
GSM549132patient 031, cancer, homogenized [OPG study]7.4191476
GSM549137patient 038, cancer, homogenized [OPG study]6.4645465
GSM549142patient 047, cancer, homogenized [OPG study]7.3582477
GSM549100patient 110, normal, homogenized [OPG study]6.694268
GSM549107patient 135, normal, homogenized [OPG study]6.3916464
GSM549115patient 068, normal, homogenized [OPG study]6.9515471
GSM549116patient 072, normal, homogenized [OPG study]7.0991272
GSM549120patient 078, normal, homogenized [OPG study]7.2065174
GSM549131patient 030, cancer, homogenized [OPG study]6.5697566
GSM549118patient 074, normal, homogenized [OPG study]8.1919183
GSM549129patient 027, cancer, homogenized [OPG study]6.8533569
GSM549123patient 088, normal, homogenized [OPG study]7.6754178
GSM549124patient 006, cancer, homogenized [OPG study]6.3836964
GSM549126patient 015, cancer, homogenized [OPG study]6.2910263
GSM549128patient 025, cancer, homogenized [OPG study]6.9891970
GSM549103patient 117, normal, homogenized [OPG study]7.0057272
GSM549117patient 073, normal, homogenized [OPG study]7.2114674
GSM549138patient 041, cancer, homogenized [OPG study]7.7582679
GSM549141patient 045, cancer, homogenized [OPG study]7.8248679
GSM549130patient 028, cancer, homogenized [OPG study]6.0863959
GSM549101patient 111, normal, homogenized [OPG study]7.0633272
GSM549105patient 128, normal, homogenized [OPG study]6.183561
GSM549106patient 134, normal, homogenized [OPG study]5.6330253
GSM549112patient 048, normal, homogenized [OPG study]6.6962668
GSM549125patient 011, cancer, homogenized [OPG study]8.0953882
GSM549127patient 024, cancer, homogenized [OPG study]6.9726670
GSM549135patient 035, cancer, homogenized [OPG study]6.4093864